Investing with, or against, CNBC’s Jim Cramer

NEW YORK, NY - OCTOBER 22: Jim Cramer of CNBC speaks during the Martha Stewart American Made Summit at Martha Stewart Living Omnimedia Headquarters on October 22, 2016 in New York City. (Photo by John Lamparski/Getty Images)

Jim Cramer of CNBC

Katherine Greifeld of Bloomberg News writes about two new ETFS that allow investors to bet either on or against the stock picks of Jim Cramer, the host of CNBC’s “Mad Money” show.

Greifeld writes, “The Inverse Cramer Tracker ETF seeks to deliver returns that correspond to ‘the inverse of securities mentioned by Cramer’ by either short-selling his equity picks or buying companies he recommends against, according to its prospectus.

“Meanwhile, the Long Cramer Tracker ETF will back shares the CNBC anchor likes and ditch the ones he doesn’t.

“The funds are the latest brainchild of the manager behind the anti-ARK product, the $551 million AXS Short Innovation Daily ETF, which achieved rapid notoriety by creating an easy way to wager against Cathie Wood’s flagship strategy. Now Matthew Tuttle, CEO of Tuttle Capital Management, has turned his attention to Cramer, fulfilling a long-running finance joke that the CNBC anchor should get his own inverse fund.”

Read more here.

Chris Roush

Chris Roush was the dean of the School of Communications at Quinnipiac University in Hamden, Connecticut. He was previously Walter E. Hussman Sr. Distinguished Professor in business journalism at UNC-Chapel Hill. He is a former business journalist for Bloomberg News, Businessweek, The Atlanta Journal-Constitution, The Tampa Tribune and the Sarasota Herald-Tribune. He is the author of the leading business reporting textbook "Show me the Money: Writing Business and Economics Stories for Mass Communication" and "Thinking Things Over," a biography of former Wall Street Journal editor Vermont Royster.